One-stage versus two-stage technique using two splinted extra-short implants: A multicentric split-mouth study with a one-year follow-up.
bone resorption
dental implants
implant stability
short implants
Journal
Clinical implant dentistry and related research
ISSN: 1708-8208
Titre abrégé: Clin Implant Dent Relat Res
Pays: United States
ID NLM: 100888977
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
revised:
05
05
2022
received:
13
09
2021
accepted:
21
05
2022
pubmed:
15
6
2022
medline:
14
10
2022
entrez:
14
6
2022
Statut:
ppublish
Résumé
To compare the clinical outcomes of extra-short implants (≤6.5 mm) inserted with one-stage versus two-stage technique in adjacent sites of the upper or lower jaw. In this split-mouth multicenter study, implants were randomly divided into two groups according to the healing phase: two-stage and one-stage technique. Primary outcome measures were implant survival, implant success, and prosthodontic complications. Secondary outcome measurements were: implant stability quotient (ISQ) collected at surgery time (T0), and after 3 (T3) and 12 (T12) months, marginal bone level (MBL) evaluated at T0, T3, T6, and T12, marginal bone loss evaluated at T6 and T12, plaque index (PI), probing depth (PD), bleeding on probing (BoP) evaluated at T3, T6, and T12. Significances of differences between groups were tested by linear mixed model with random intercept. Nineteen patients (8 males and 11 females) were included. A total of 38 implants were inserted. At T12 implant cumulative survival and implant success rate were 100% in both groups. No statistically significant differences were recorded for any of the analyzed parameters between the two groups at any time point. ISQ values were similar at T0 (two-stage: mean 67.53 ± SD 19.47; one-stage: mean 66.53 ± 19.07 p = 0.8738) and increased in both groups at the 12-month follow-up appointment (two-stage: 81.1 ± 7.04; one-stage: 81.39 ± 0.9266). MBL values were similar in the two groups at any time point. At T12 marginal bone loss was 0.46 ± 0.41 (two-stage) and 0.45 ± 0.38 (one-stage) mm (p = 0.9417), while mean PD was 2.7 ± 0.85 (two-stage) and 2.69 ± 0.89 (one-stage) mm. Within the limits of the present short-term report, extra-short implants demonstrated optimal clinical outcomes using the one-stage technique, without statistically significant differences compared with the traditional two-stage approach.
Identifiants
pubmed: 35700161
doi: 10.1111/cid.13113
pmc: PMC9796435
doi:
Substances chimiques
Dental Implants
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
602-610Subventions
Organisme : BTI group
Informations de copyright
© 2022 The Authors. Clinical Implant Dentistry and Related Research published by Wiley Periodicals LLC.
Références
Eur J Oral Implantol. 2009 Summer;2(2):91-9
pubmed: 20467608
J Prosthodont. 2019 Feb;28(2):e688-e693
pubmed: 29377338
Int J Prosthodont. 2015 Nov-Dec;28(6):627-30
pubmed: 26523725
J Craniomaxillofac Surg. 2019 Apr;47(4):651-660
pubmed: 30799134
J Stomatol Oral Maxillofac Surg. 2019 Feb;120(1):28-37
pubmed: 30453101
J Dent (Shiraz). 2017 Dec;18(4):272-276
pubmed: 29201970
Int J Oral Maxillofac Implants. 2017 Sep 22;33(1):41–50
pubmed: 28938030
Int J Oral Maxillofac Implants. 2007 Jan-Feb;22(1):138-45
pubmed: 17340908
J Dent. 2015 Feb;43(2):149-70
pubmed: 25239770
Clin Implant Dent Relat Res. 2022 Feb;24(1):43-71
pubmed: 35048503
Int J Oral Maxillofac Implants. 2017 Sep 22;33(1):87–100
pubmed: 28938035
Int J Oral Maxillofac Implants. 2014 May-Jun;29(3):682-9
pubmed: 24818208
Int J Oral Maxillofac Implants. 2005 Nov-Dec;20(6):930-7
pubmed: 16392351
Int J Oral Maxillofac Implants. 2019 Jan/Feb;34(1):68-84
pubmed: 30695086
J Dent Res. 2012 Sep;91(9):821-7
pubmed: 22851285
Clin Oral Implants Res. 2015 Sep;26 Suppl 11:iii-iv
pubmed: 26385632
Int J Oral Maxillofac Surg. 2021 Sep;50(9):1249-1258
pubmed: 33589294
J Clin Periodontol. 2018 May;45(5):613-623
pubmed: 29574852
J Periodontol. 2022 Jan;93(1):135-145
pubmed: 34008185
J Periodontol. 1999 Mar;70(3):248-54
pubmed: 10225540
J Adv Prosthodont. 2018 Jun;10(3):191-196
pubmed: 29930788
Int J Periodontics Restorative Dent. 2010 Feb;30(1):89-95
pubmed: 20224835
J Clin Med. 2021 Oct 27;10(21):
pubmed: 34768518
Clin Oral Implants Res. 2018 Oct;29 Suppl 18:243-252
pubmed: 30306696
Med Oral Patol Oral Cir Bucal. 2019 Jan 1;24(1):e70-e75
pubmed: 30573711
J Biol Regul Homeost Agents. 2018 Jul-Aug;32(4):1015-1020
pubmed: 30043587
Clin Implant Dent Relat Res. 2018 Feb;20(1):9-20
pubmed: 29193558
Clin Implant Dent Relat Res. 2022 Oct;24(5):602-610
pubmed: 35700161
Implant Dent. 2014 Apr;23(2):180-7
pubmed: 24637523
J Periodontol. 2007 Mar;78(3):377-96
pubmed: 17335361
Implant Dent. 2019 Dec;28(6):590-602
pubmed: 31274666
Dent Today. 2005 Aug;24(8):64-6, 68
pubmed: 16161821
Int J Oral Maxillofac Surg. 2014 Jun;43(6):748-57
pubmed: 24530034
Minerva Stomatol. 2016 Aug;65(4):231-8
pubmed: 27035270
Int J Prosthodont. 2019 Jan/Feb;32(1):27-31
pubmed: 30677109
Int J Oral Implantol (Berl). 2019;12(2):169-179
pubmed: 31090748
Int J Prosthodont. 2008 Nov-Dec;21(6):539-42
pubmed: 19149073
J Oral Maxillofac Res. 2015 Mar 30;6(1):e2
pubmed: 25937873
Implant Dent. 2019 Dec;28(6):551-555
pubmed: 31765332